Sponsor pipeline

RemeGen Co., Ltd. clinical trial pipeline

Get alerts when RemeGen Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

Show 2 trials with minor changes only
  1. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-14 NCT07874282 Phase II Study to Evaluate Telisotuzumab Adizutecan in Combination With RC148 as… Phase 2 Not Yet Recruiting
2026-09-21 NCT07829549 Phase III Study of RC148 Plus Chemotherapy Versus Tislelizumab Plus Chemotherapy as… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
6
Phase 2
9
Phase 2/3
3
Phase 3
9

Disease areas by active trials

Lung Cancer (6) · Non-Small Cell Lung Cancer (NSCLC) (6) · Breast Cancer (5) · Gastric Cancer (5) · Bladder Cancer (3) · Cervical Cancer (1) · Colorectal Cancer (1) · Myasthenia Gravis (1)

Get alerts when RemeGen Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free